ML Randi, E Ruzzon, G Luzzatto, F Tezza, A Girolami and F Fabris (2005) “Safety profile of hydroxyurea in the treatment of patients with Philadelphia-negative chronic myeloproliferative disorders”, Haematologica. Pavia, Italy, 90(2), pp. 261-262. doi: 10.3324/%x.